Growth Metrics

Rhythm Pharmaceuticals (RYTM) Debt to Equity (2016 - 2025)

Historic Debt to Equity for Rhythm Pharmaceuticals (RYTM) over the last 5 years, with Q3 2025 value amounting to $0.73.

  • Rhythm Pharmaceuticals' Debt to Equity changed N/A to $0.73 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.73, marking a year-over-year change of. This contributed to the annual value of $5.05 for FY2024, which is 70824.61% up from last year.
  • Rhythm Pharmaceuticals' Debt to Equity amounted to $0.73 in Q3 2025.
  • Over the past 5 years, Rhythm Pharmaceuticals' Debt to Equity peaked at $5.78 during Q1 2025, and registered a low of -$9.22 during Q2 2025.
  • In the last 3 years, Rhythm Pharmaceuticals' Debt to Equity had a median value of $0.73 in 2025 and averaged $0.59.
  • Within the past 5 years, the most significant YoY rise in Rhythm Pharmaceuticals' Debt to Equity was 70824.61% (2024), while the steepest drop was 70824.61% (2024).
  • Rhythm Pharmaceuticals' Debt to Equity (Quarter) stood at $0.63 in 2023, then skyrocketed by 708.25% to $5.05 in 2024, then tumbled by 85.51% to $0.73 in 2025.
  • Its last three reported values are $0.73 in Q3 2025, -$9.22 for Q2 2025, and $5.78 during Q1 2025.